341 related articles for article (PubMed ID: 25338927)
1. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.
Cady R; Saper J; Dexter K; Manley HR
Headache; 2015 Jan; 55(1):101-16. PubMed ID: 25338927
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.
Cady RK; Saper J; Dexter K; Cady RJ; Manley HR
Headache; 2015 Apr; 55(4):529-42. PubMed ID: 25828648
[TBL] [Abstract][Full Text] [Related]
3. A novel revision to the classical transnasal topical sphenopalatine ganglion block for the treatment of headache and facial pain.
Candido KD; Massey ST; Sauer R; Darabad RR; Knezevic NN
Pain Physician; 2013; 16(6):E769-78. PubMed ID: 24284858
[TBL] [Abstract][Full Text] [Related]
4. Lidocaine Versus Bupivacaine in the Treatment of Headache with Intranasal Sphenopalatine Nerve Block.
Kirkpatrick DL; Townsend T; Walter C; Clark L; Alli A; Fahrbach T; Madarang EJ; Lemons S; Reeves A; Collins Z
Pain Physician; 2020 Jul; 23(4):423-428. PubMed ID: 32709177
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive sphenopalatine ganglion block for acute headache in the emergency department: a randomized placebo-controlled trial.
Schaffer JT; Hunter BR; Ball KM; Weaver CS
Ann Emerg Med; 2015 May; 65(5):503-10. PubMed ID: 25577713
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Regional Anesthetic Sphenopalatine Ganglion Block on Self-Reported Pain in Patients With Status Migrainosus.
Mehta D; Leary MC; Yacoub HA; El-Hunjul M; Kincaid H; Koss V; Wachter K; Malizia D; Glassman B; Castaldo JE
Headache; 2019 Jan; 59(1):69-76. PubMed ID: 30043973
[TBL] [Abstract][Full Text] [Related]
7. Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study.
Crespi J; Bratbak D; Dodick D; Matharu M; Jamtøy KA; Aschehoug I; Tronvik E
J Headache Pain; 2018 Feb; 19(1):14. PubMed ID: 29442191
[TBL] [Abstract][Full Text] [Related]
8. Resting State Functional Connectivity After Sphenopalatine Ganglion Blocks in Chronic Migraine With Medication Overuse Headache: A Pilot Longitudinal fMRI Study.
Krebs K; Rorden C; Androulakis XM
Headache; 2018 May; 58(5):732-743. PubMed ID: 29878344
[TBL] [Abstract][Full Text] [Related]
9. Sphenopalatine Ganglion Nerve Block for the Treatment of Migraine Headaches in the Pediatric Population.
Mousa MA; Aria DJ; Mousa AA; Schaefer CM; Temkit MHH; Towbin RB
Pain Physician; 2021 Jan; 24(1):E111-E116. PubMed ID: 33400444
[TBL] [Abstract][Full Text] [Related]
10. Transnasal Sphenopalatine Ganglion Block for the Preventive Treatment of Chronic Daily Headache in Adolescents.
Kouri M; Somaini M; Cárdenas VHG; Niburski K; Vigouroux M; Ingelmo P
Children (Basel); 2021 Jul; 8(7):. PubMed ID: 34356585
[TBL] [Abstract][Full Text] [Related]
11. Sphenopalatine Ganglion Block in the Management of Chronic Headaches.
Mojica J; Mo B; Ng A
Curr Pain Headache Rep; 2017 Jun; 21(6):27. PubMed ID: 28432602
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study.
Gul HL; Ozon AO; Karadas O; Koc G; Inan LE
Acta Neurol Scand; 2017 Aug; 136(2):138-144. PubMed ID: 27910088
[TBL] [Abstract][Full Text] [Related]
13. Hemicrania continua may respond to repetitive sphenopalatine ganglion block: A case report.
Androulakis XM; Krebs KA; Ashkenazi A
Headache; 2016 Mar; 56(3):573-9. PubMed ID: 26926875
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of preemptive sphenopalatine ganglion block on postoperative pain and functional outcomes after functional endoscopic sinus surgery.
Cho DY; Drover DR; Nekhendzy V; Butwick AJ; Collins J; Hwang PH
Int Forum Allergy Rhinol; 2011; 1(3):212-8. PubMed ID: 22287376
[TBL] [Abstract][Full Text] [Related]
15. Sphenopalatine Ganglion Blocks in the Management of Head and Neck Cancer-Related Pain: A Case Series.
Pena I; Knoepfler ML; Irwin A; Zhu X; Kohan LR
A A Pract; 2019 Dec; 13(12):450-453. PubMed ID: 31609721
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura?
Palamar D; Uluduz D; Saip S; Erden G; Unalan H; Akarirmak U
Pain Physician; 2015; 18(2):153-62. PubMed ID: 25794201
[TBL] [Abstract][Full Text] [Related]
17. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
Dilli E; Halker R; Vargas B; Hentz J; Radam T; Rogers R; Dodick D
Cephalalgia; 2015 Oct; 35(11):959-68. PubMed ID: 25505035
[TBL] [Abstract][Full Text] [Related]
18. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study.
Inan LE; Inan N; Karadaş Ö; Gül HL; Erdemoğlu AK; Türkel Y; Akyol A
Acta Neurol Scand; 2015 Oct; 132(4):270-7. PubMed ID: 25765043
[TBL] [Abstract][Full Text] [Related]
19. Cortical and subcortical changes following sphenopalatine ganglion blocks in chronic migraine with medication overuse headache: a preliminary longitudinal study.
Newman-Norlund RD; Rorden C; Maleki N; Patel M; Cheng B; Androulakis XM
Womens Midlife Health; 2020; 6():7. PubMed ID: 32774872
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA
Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
